Sub-communities within this community

Recent Submissions

1. Correspondence on 'Enhanced recovery after surgery in gynecologic oncology: time to address barriers to implementation in low- and middle-income countries' by Nelson et al

   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, v.31, n.11, p.1497-1497, 2021

2. The feared postdilation complication in caustic esophageal stenosis: combined endoscopic and surgical treatment

   ENDOSCOPY, v.53, n.12, p.E446-E447, 2021

3. Mepolizumab in Hypereosinophilic Syndrome: A Systematic Review and Meta-analysis

   CLINICS, v.76, article ID e3271, 7p, 2021

   We aimed to evaluate the efficacy and safety of mepolizumab (MEP) in the management of hypereosinophilic syndrome (HES). A systematic search was performed, and articles published until March 2021 were analyzed. The primary efficacy results evaluated were hospitalization rate related to HES, morbi...

4. Ten papers for teachers of evidence-based medicine and health care: Sicily workshop 2019

   BMJ EVIDENCE-BASED MEDICINE, v.26, n.5, p.224-227, 2021

5. Professional transitions in medicine - switching medical specialties

   SAUDE E SOCIEDADE, v.30, n.4, article ID e200677, 12p, 2021

   Professional transitions in Medicine are particularly difficult for physicians due to the costs and duration of medical education. This study sought to understand the experiences of physicians who have changed specialties, analyzing motivations and meanings underlying such transition. This is a q...

6. Use of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: a systematic review and meta-analysis

   JORNAL BRASILEIRO DE PNEUMOLOGIA, v.47, n.5, article ID e20210236, 11p, 2021

   Objective: Chloroquine or hydroxychloroquine has demonstrated no effect on the treatment of hospitalized COVID-19 patients. This study aimed to answer questions related to the use of hydroxychloroquine for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection and in the treatment of p...

7. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

   LANCET NEUROLOGY, v.18, n.1, p.88-106, 2019

   Background The number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding of the dementia disease burden. We aimed to present the first...

8. Depression as a determinant of frailty in late life

   AGING & MENTAL HEALTH, v.25, n.12, p.2279-2285, 2021

   Objectives Accumulating evidence shows depression as a risk factor for frailty, but studies are mainly population-based and widely differ in their assessment of either depression or frailty. We investigated the association between depression and frailty among geriatric outpatients using different...

9. Dimensions of Anger Reactions (DAR-5): a useful screening tool for anger in the general population

   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, v.25, n.4, p.421-429, 2021

   Background Dimensions of Anger Reactions (DAR-5) is a brief 5-item instrument to assess experience of anger. We aimed to verify the DAR-5 as a screening instrument in the community. Methods A sample of 368 apparently healthy adults who attended an outpatient ambulatory facility self-reported on t...

10. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016

    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, v.77, n.3, p.133-141, 2020

    Objectives This study provides an overview of the influence of occupational risk factors on the global burden of disease as estimated by the occupational component of the Global Burden of Disease (GBD) 2016 study. Methods The GBD 2016 study estimated the burden in terms of deaths and disability-a...